Human Reproduction, Vol. 14, No. 6, 1457-1460,
June 1999
© 1999 European Society of Human Reproduction and Embryology
Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety
S.I.S.ME.R., Reproductive Medicine Unit, Via Mazzini 12, 40138, Bologna, Italy
In a prospective randomized study, we analysed 125 patients at risk of ovarian hyperstimulation syndrome (OHSS), selected in the period between January 1996 and July 1997. All the patients had blood oestradiol concentration 
1500 pg/ml on the day of human chorionic gonadotrophin (HCG) administration and 15 oocytes were collected. The patients were matched in two groups: group A, control group (n = 67), had fresh embryo transfers; group B (n = 58) had cryopreservation of all obtained pronucleate embryos. Pregnancy, live birth rates and the incidence of OHSS were compared between the two groups. There were no significant differences in terms of pregnancies per patient (46.3 versus 48.3%) and live birth rates (38.8 versus 39.6%). No cases of OHSS occurred in group B, while four patients developed the syndrome in group A. The implantation rate was slightly but not significantly lower in group B (
2 = 1.03). These results suggest that elective cryopreservation of all zygotes might prevent the risk of OHSS in patients undergoing IVF treatment. In contrast to what has been reported by other authors, our results show that the elective cryopreservation of zygotes does not affect pregnancy and live birth rates.
Key words: cryopreservation/embryo/ovarian hyperstimulation/thawing/zygotes
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. B. Sheehan, M. Lane, and D. K. Gardner The CryoLoop facilitates re-vitrification of embryos at four successive stages of development without impairing embryo growth Hum. Reprod., November 1, 2006; 21(11): 2978 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Gustofson, J. H. Segars, and F. W. Larsen Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome Hum. Reprod., November 1, 2006; 21(11): 2830 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Magli, L. Gianaroli, N. Grieco, E. Cefalu, G. Ruvolo, and A.P. Ferraretti Cryopreservation of biopsied embryos at the blastocyst stage Hum. Reprod., October 1, 2006; 21(10): 2656 - 2660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Endo, H. Honnma, T. Hayashi, M. Chida, K. Yamazaki, Y. Kitajima, A. Azumaguchi, H. Kamiya, and R. Kudo Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos Hum. Reprod., October 1, 2002; 17(10): 2548 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Ulug, M. Bahceci, H. F. Erden, E. Shalev, and I. Ben-Shlomo The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles Hum. Reprod., February 1, 2002; 17(2): 310 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome Hum. Reprod., January 1, 2002; 17(1): 107 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.E. Egbase, M.A. Sharhan, P. Berlingieri, and J.G. Grudzinskas Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment Hum. Reprod., October 1, 2000; 15(10): 2082 - 2086. [Abstract] [Full Text] [PDF]
|
|